147 related articles for article (PubMed ID: 17538956)
21. Opposite effects of clozapine and sulpiride on the lipopolysaccharide-induced inhibition of the GR-mediated gene transcription in fibroblast cells.
Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Leśkiewicz M; Tetich M; Kubera M; Scharpe S; Lasoń W
Pol J Pharmacol; 2003; 55(6):1153-8. PubMed ID: 14730115
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid-induced apoptosis in lymphocytes.
Planey SL; Litwack G
Biochem Biophys Res Commun; 2000 Dec; 279(2):307-12. PubMed ID: 11118283
[TBL] [Abstract][Full Text] [Related]
23. Identification of molecular targets for dietary energy restriction prevention of skin carcinogenesis: an idea cultivated by Edward Bresnick.
Birt DF; Przybyszewski J; Wang W; Stewart J; Liu Y
J Cell Biochem; 2004 Feb; 91(2):258-64. PubMed ID: 14743386
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells.
Sommer P; Le Rouzic P; Gillingham H; Berry A; Kayahara M; Huynh T; White A; Ray DW
Oncogene; 2007 Nov; 26(50):7111-21. PubMed ID: 17496926
[TBL] [Abstract][Full Text] [Related]
25. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.
Sengupta S; Wasylyk B
Ann N Y Acad Sci; 2004 Jun; 1024():54-71. PubMed ID: 15265773
[TBL] [Abstract][Full Text] [Related]
26. Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor.
Pérez P; Page A; Bravo A; Del Río M; Giménez-Conti I; Budunova I; Slaga TJ; Jorcano JL
FASEB J; 2001 Sep; 15(11):2030-2. PubMed ID: 11511512
[TBL] [Abstract][Full Text] [Related]
27. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
28. Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems.
De Bosscher K; Van Craenenbroeck K; Meijer OC; Haegeman G
Eur J Pharmacol; 2008 Apr; 583(2-3):290-302. PubMed ID: 18289525
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.
Yang BV; Vaccaro W; Doweyko AM; Doweyko LM; Huynh T; Tortolani D; Nadler SG; McKay L; Somerville J; Holloway DA; Habte S; Weinstein DS; Barrish JC
Bioorg Med Chem Lett; 2009 Apr; 19(8):2139-43. PubMed ID: 19321341
[TBL] [Abstract][Full Text] [Related]
30. [Induction of apoptosis in lymphocytes by glucocorticoids: between physiology and pharmacology].
Pallardy M; Biola A
C R Seances Soc Biol Fil; 1998; 192(6):1051-63. PubMed ID: 10101602
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
32. The effect of CAG repeat length polymorphism in the murine glucocorticoid receptor on transactivation potential.
Yee KS; Cho K; Green T; Chandler J; Greenhalgh DG
Exp Mol Pathol; 2008 Jun; 84(3):200-5. PubMed ID: 18538320
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid receptor is required for skin barrier competence.
Bayo P; Sanchis A; Bravo A; Cascallana JL; Buder K; Tuckermann J; Schütz G; Pérez P
Endocrinology; 2008 Mar; 149(3):1377-88. PubMed ID: 18039792
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids and vulnerability to psychostimulant drugs: toward substrate and mechanism.
de Jong IE; de Kloet ER
Ann N Y Acad Sci; 2004 Jun; 1018():192-8. PubMed ID: 15240368
[TBL] [Abstract][Full Text] [Related]
35. Negative regulatory role of annexin-A1 in 14-3-3eta-mediated glucocorticoid receptor transcriptional activation.
Sung HJ; Ryang YS; Kim YS; Jang SW; Na DS; Ko J
Biochem Biophys Res Commun; 2006 Jan; 339(4):1208-11. PubMed ID: 16338219
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis.
Birt DF; Yaktine A; Duysen E
J Nutr; 1999 Feb; 129(2S Suppl):571S-574S. PubMed ID: 10064335
[TBL] [Abstract][Full Text] [Related]
37. Bag-1M is a component of the in vivo DNA-glucocorticoid receptor complex at hormone-regulated promoter.
Hong W; Baniahmad A; Liu Y; Li H
J Mol Biol; 2008 Dec; 384(1):22-30. PubMed ID: 18822299
[TBL] [Abstract][Full Text] [Related]
38. Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter.
Dschietzig T; Bartsch C; Wessler S; Baumann G; Stangl K
Regul Pept; 2009 Jun; 155(1-3):163-73. PubMed ID: 19289144
[TBL] [Abstract][Full Text] [Related]
39. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
Ayroldi E; Macchiarulo A; Riccardi C
FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
Chinenov Y; Rogatsky I
Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
